Inventor · disambiguated record
Mustafa Guzel
Also filed as: BLOCH PAW · GUZEL MUSTAFA · GÜZEL MUSTAFA
35 granted patents·5 pending applications·561 citations·filing 2002–2023
98Inventor score
Files withVTV THERAPEUTICS LLC13TRANSTECH PHARMA INC5TRANSTECH PHARMA LLC5MJALLI ADNAN M M4NOVO NORDISK AS4
Top patents by PatentIndex Score
40 records- 0198US7541373B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2006·Granted Jun 2, 2009·123 cites·22 claims
- 0298US7384967B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2003·Granted Jun 10, 2008·166 cites·108 claims
- 0397US7459472B2Aryl and heteroaryl compounds, compositions, and methods of useTRANSTECH PHARMA INC·Filed 2004·Granted Dec 2, 2008·92 cites·35 claims
- 0496USRE45670EAryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2013·Granted Sep 15, 2015·34 cites·22 claims
- 0595US10287284B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2018·Granted May 14, 2019·14 cites·22 claims
- 0693US11130753B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Sep 28, 2021·2 cites·29 claims
- 0792US9393245B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2015·Granted Jul 19, 2016·7 cites·11 claims
- 0892US8759535B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofMJALLI ADNAN M M·Filed 2011·Granted Jun 24, 2014·15 cites·49 claims
- 0991US7906507B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2010·Granted Mar 15, 2011·12 cites·17 claims
- 1091US7897628B2Aryl carbonyl derivatives as therapeutic agentsNOVO NORDISK AS·Filed 2007·Granted Mar 1, 2011·15 cites·22 claims
- 1190US11649230B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2021·Granted May 16, 2023·1 cites·29 claims
- 1290US10889580B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2020·Granted Jan 12, 2021·2 cites·20 claims
- 1390US8329715B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsMJALLI ADNAN M M·Filed 2012·Granted Dec 11, 2012·10 cites·19 claims
- 1490US7790714B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2010·Granted Sep 7, 2010·10 cites·28 claims
- 1590US7727983B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA INC·Filed 2009·Granted Jun 1, 2010·11 cites·46 claims
- 1686US8703766B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2013·Granted Apr 22, 2014·6 cites·17 claims
- 1785US10568888B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·16 claims
- 1885US10391097B2Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2018·Granted Aug 27, 2019·2 cites·16 claims
- 1985US8524708B2Oxadiazoanthracene compounds for the treatment of diabetesMJALLI ADNAN M M·Filed 2010·Granted Sep 3, 2013·6 cites·17 claims
- 2083US10570126B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2019·Granted Feb 25, 2020·2 cites·21 claims
- 2183US8063081B2Aryl carbonyl derivatives as therapeutic agentsPOLISETTI DHARMA RAO·Filed 2007·Granted Nov 22, 2011·6 cites·17 claims
- 2282US9120813B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2014·Granted Sep 1, 2015·4 cites·17 claims
- 2381US8933222B2Oxadiazoanthracene compounds for the treatment of diabetesTRANSTECH PHARMA LLC·Filed 2014·Granted Jan 13, 2015·3 cites·4 claims
- 2480US10085990B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Oct 2, 2018·1 cites·16 claims
- 2580US9833457B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2017·Granted Dec 5, 2017·1 cites·19 claims
- 2679US9175003B2Substituted azoanthracene derivatives and intermediates for preparation thereofTRANSTECH PHARMA LLC·Filed 2015·Granted Nov 3, 2015·2 cites·11 claims
- 2778US10030011B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 2878US9687489B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsVTV THERAPEUTICS LLC·Filed 2016·Granted Jun 27, 2017·1 cites·11 claims
- 2977US8987295B2Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereofTRANSTECH PHARMA LLC·Filed 2012·Granted Mar 24, 2015·3 cites·22 claims
- 3077US8383644B2Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereofTRANSTECH PHARMA INC·Filed 2010·Granted Feb 26, 2013·3 cites·25 claims
- 3176US9163022B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsHIGH POINT PHARMACEUTICALS LLC·Filed 2014·Granted Oct 20, 2015·1 cites·19 claims
- 3275US7964608B2Tricyclic compounds as modulators of TNF-α synthesisHIGH POINT PHARMACEUTICALS LLC·Filed 2009·Granted Jun 21, 2011·1 cites·48 claims
- 3374US8853226B2Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitorsMJALLI ADNAN M M·Filed 2011·Granted Oct 7, 2014·1 cites·11 claims
- 3463US12091407B2Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereofVTV THERAPEUTICS LLC·Filed 2023·Granted Sep 17, 2024·0 cites·28 claims
- 3554US2011301158A1Aryl carbonyl derivatives as therapeutic agentsPOLISETTI DHARMA RAO·Filed 2011·Application pending·0 cites
- 3643US2010036150A1Mandelic acid derivatives and preparation thereofPOLISETTI DHARMA RAO·Filed 2007·Application pending·0 cites
- 3743US2003171411A1Amide derivatives as therapeutic agentsFiled 2002·Application pending·0 cites
- 3839US2012071505A1Substituted pyridine derivatives, pharmaceutical compositions, and methods of use to treat oxidative stressGADDAM BAPU·Filed 2011·Application pending·0 cites
- 3935US2022143005A1Naphthalimide derivatives as anti-parasitic agents for the treatment of leishmaniasis as well as viral, bacterial and neoplastic diseasesUNIV ISTANBUL MEDIPOL·Filed 2019·Application pending·0 cites
- 4032US11053270B2Heterobivalent ligands suitable for use in the treatment of Parkinson's diseaseT C ISTANBUL MEDIPOL UENIVERSITESI·Filed 2018·Granted Jul 6, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Mustafa Guzel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →